Cargando…
Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma
Glioblastoma (GBM) is an essentially incurable and rapidly fatal cancer, with few markers predicting a favourable prognosis. Here we report that the transcription factor NFIB is associated with significantly improved survival in GBM. NFIB expression correlates inversely with astrocytoma grade and is...
Autores principales: | Stringer, Brett W., Bunt, Jens, Day, Bryan W., Barry, Guy, Jamieson, Paul R., Ensbey, Kathleen S., Bruce, Zara C., Goasdoué, Kate, Vidal, Hélène, Charmsaz, Sara, Smith, Fiona M., Cooper, Leanne T., Piper, Michael, Boyd, Andrew W., Richards, Linda J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045397/ https://www.ncbi.nlm.nih.gov/pubmed/27083054 http://dx.doi.org/10.18632/oncotarget.8720 |
Ejemplares similares
-
PAX6 does not regulate Nfia and Nfib expression during neocortical development
por: Bunt, Jens, et al.
Publicado: (2015) -
Combined allelic dosage of Nfia and Nfib regulates cortical development
por: Bunt, Jens, et al.
Publicado: (2017) -
A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma
por: Stringer, Brett W., et al.
Publicado: (2019) -
Publisher Correction: A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma
por: Stringer, Brett W., et al.
Publicado: (2020) -
EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma
por: Offenhäuser, Carolin, et al.
Publicado: (2018)